Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0444 Transporter Info | ||||
Gene Name | SLC6A12 | ||||
Transporter Name | Na(+)/Cl(-) betaine/GABA transporter | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Ovarian cancer |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Hypomethylation of SLC6A12 in ovarian cancer | [ 1 ] | |||
Location |
Promoter | ||||
Epigenetic Type |
Methylation | Experiment Method | Methylation-specific PCR | ||
Related Molecular Changes | Up regulation ofSLC6A12 | Experiment Method | RT-qPCR | ||
Studied Phenotype |
Ovarian cancer[ ICD-11:2C73] | ||||
Experimental Material |
Multiple cell lines of human | ||||
Additional Notes |
SLC6A12 had decreased methylation and increased expression in ovarian cancer. | ||||
Bladder cancer |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC6A12 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg10508416) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.64E+00 | Statistic Test | p-value:2.48E-09; Z-score:-6.72E+00 | ||
Methylation in Case |
4.25E-01 (Median) | Methylation in Control | 6.98E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC6A12 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg06823681) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.23E+00 | Statistic Test | p-value:6.06E-15; Z-score:-2.96E+00 | ||
Methylation in Case |
6.04E-01 (Median) | Methylation in Control | 7.44E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC6A12 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg10508416) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.05E+00 | Statistic Test | p-value:5.30E-04; Z-score:-7.22E-01 | ||
Methylation in Case |
6.60E-01 (Median) | Methylation in Control | 6.91E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC6A12 in colorectal cancer | [ 4 ] | |||
Location |
TSS1500 (cg10508416) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.12E+00 | Statistic Test | p-value:7.52E-12; Z-score:-4.21E+00 | ||
Methylation in Case |
7.60E-01 (Median) | Methylation in Control | 8.52E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC6A12 in colorectal cancer | [ 4 ] | |||
Location |
TSS1500 (cg06823681) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.09E+00 | Statistic Test | p-value:1.28E-06; Z-score:-1.71E+00 | ||
Methylation in Case |
7.78E-01 (Median) | Methylation in Control | 8.48E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC6A12 in HIV infection | [ 5 ] | |||
Location |
TSS1500 (cg06823681) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.16E+00 | Statistic Test | p-value:8.31E-06; Z-score:-3.05E+00 | ||
Methylation in Case |
6.93E-01 (Median) | Methylation in Control | 8.06E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC6A12 in HIV infection | [ 5 ] | |||
Location |
TSS1500 (cg10508416) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.06E+00 | Statistic Test | p-value:2.16E-04; Z-score:-1.46E+00 | ||
Methylation in Case |
7.72E-01 (Median) | Methylation in Control | 8.19E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC6A12 in lung adenocarcinoma | [ 6 ] | |||
Location |
TSS1500 (cg06823681) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.18E+00 | Statistic Test | p-value:8.66E-07; Z-score:-4.20E+00 | ||
Methylation in Case |
6.61E-01 (Median) | Methylation in Control | 7.82E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC6A12 in lung adenocarcinoma | [ 6 ] | |||
Location |
TSS1500 (cg10508416) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.10E+00 | Statistic Test | p-value:2.30E-03; Z-score:-2.61E+00 | ||
Methylation in Case |
7.15E-01 (Median) | Methylation in Control | 7.88E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC6A12 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
TSS1500 (cg02998017) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:1.77E-05; Z-score:-7.12E-01 | ||
Methylation in Case |
8.19E-01 (Median) | Methylation in Control | 8.38E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC6A12 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
TSS1500 (cg01178971) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.10E+00 | Statistic Test | p-value:2.53E-02; Z-score:5.91E-01 | ||
Methylation in Case |
5.08E-01 (Median) | Methylation in Control | 4.64E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC6A12 in panic disorder | [ 8 ] | |||
Location |
TSS1500 (cg06823681) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.11E+00 | Statistic Test | p-value:2.49E-02; Z-score:4.65E-01 | ||
Methylation in Case |
1.93E+00 (Median) | Methylation in Control | 1.74E+00 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC6A12 in hepatocellular carcinoma | [ 9 ] | |||
Location |
Body (cg19521693) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.73E+00 | Statistic Test | p-value:2.86E-20; Z-score:-2.60E+00 | ||
Methylation in Case |
1.75E-01 (Median) | Methylation in Control | 3.02E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Prostate cancer |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC6A12 in prostate cancer | [ 10 ] | |||
Location |
Body (cg09660365) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.25E+00 | Statistic Test | p-value:8.84E-03; Z-score:1.96E+01 | ||
Methylation in Case |
4.99E-01 (Median) | Methylation in Control | 2.22E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
microRNA |
|||||
Unclear Phenotype |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
miR-335 directly targets SLC6A12 | [ 11 ] | |||
Epigenetic Type |
microRNA | Experiment Method | Microarray | ||
miRNA Stemloop ID |
miR-335 | miRNA Mature ID | miR-335-5p | ||
miRNA Sequence |
UCAAGAGCAAUAACGAAAAAUGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon2 |
miR-342 directly targets SLC6A12 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | CLASH | ||
miRNA Stemloop ID |
miR-342 | miRNA Mature ID | miR-342-3p | ||
miRNA Sequence |
UCUCACACAGAAAUCGCACCCGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.